Companion Animal Vaccines Market - By Vaccine Type (Live Attenuated, Inactivated, Recombinant), By Animal Type (Canine, Feline, Equine, Avian), By Route of Administration (Injection Vaccines, Oral Vaccines, Spray Vaccines) By Distribution Channel & Forecast, 2023-2032

Published Date: July - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Animal Health and Nutrition | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Companion Animal Vaccines Market - By Vaccine Type (Live Attenuated, Inactivated, Recombinant), By Animal Type (Canine, Feline, Equine, Avian), By Route of Administration (Injection Vaccines, Oral Vaccines, Spray Vaccines) By Distribution Channel & Forecast, 2023-2032

Companion Animal Vaccines Market Size

Companion Animal Vaccines Market size accounted for over USD 3 billion in 2022 and is estimated to grow at 6.6% CAGR between 2023 and 2032. High disposable income and rising prevalence of zoonotic diseases has augmented the global market growth.

To get key market trends

  Download Free Sample

Pets are largely adopted in developed countries such as Germany and U.S. majorly by elderly people for companionship. For instance, in 2022, according to the American Pet Products Association (APPA), 70% of U.S. households owns a pet. Also there has been a change in drift from pet owners to pet parents that displays pets are considered as a part of the family nowadays. Thus, increasing adoption of pets accelerates demand for companion animal vaccines market growth.
 

Companion Animal Vaccines Market Report Attributes
Report Attribute Details
Base Year 2022
Companion Animal Vaccines Market Size in 2022 USD 3 Billion
Forecast Period 2023 to 2032
Forecast Period 2023 to 2032 CAGR 6.6%
2032 Value Projection USD 5.9 Billion
Historical Data for 2018 to 2022
No. of Pages 200
Tables, Charts & Figures 392
Segments covered Vaccine Type, Animal Type, Route of Administration, Distribution Channel, and Region
Growth Drivers
  • Increasing number of pet adoption
  • Rising prevalence of zoonotic diseases
  • Growing awareness about companion animal vaccination
  • Increasing government initiatives for companion animal vaccination
Pitfalls & Challenges
  • High cost of vaccine development
  • Stringent regulatory scenario for vaccine development

What are the growth opportunities in this market?

 Download Free Sample

Companion animal vaccines are biological formulations developed to protect animals from bacterial, viral, and fungal infections caused by pathogens. Companion animal vaccines are considered an effective medium to prevent diseases, and aids in limiting the disease burden in pet animals. These vaccines play an anchoring role in improving the health and welfare of animals, promoting pet health, and restrict pathogenic animal to human transmission.

Covid-19 Impact

Hey there! So, this crazy COVID-19 thing actually had a positive side for our furry friends, believe it or not. People were stuck at home, and guess what they did? They got lots of pets! Animal shelters saw a major boom in adoptions, and more people than ever became pet owners. And here's the thingCOVID-19 can spread from humans to animals, and pets aren't immune. In fact, we've seen quite a few cases of cats and dogs getting infected. So, what did that mean? More pet owners were like, "Hey, we need to protect our furry pals!" And that's where vaccines came in. People wanted to keep their pets safe from this scary virus, so they were spending more money on vaccines. That's why the companion animal vaccines market actually saw a boost during the pandemic. It was like, "More pets, more concern, more vaccines!" So, it's not all bad news after all. Our pets got more loving homes, and they're staying healthy too!

Companion Animal Vaccines Market Trends

As more diseases jump from animals to humans worldwide, the demand for vaccines for pets is likely to skyrocket in the years to come. These "zoonotic" diseases are a serious threat to humans because they can be transferred through contact with infected animals. They can cause a wide range of symptoms, from mild to deadly. In fact, we've seen a rise in diseases like SARS, bird flu, and rabies, which can be deadly if not treated. Since these diseases affect both animals and humans, the growing number of cases worldwide has created a strong demand for accurate diagnosis and prevention. And that's where companion animal vaccines come in.

Lack of well-developed infrastructure and stringent regulatory scenario for vaccine development may impede the market growth

Lack of well-developed infrastructure & resources for vaccine development and limited expenditure on pet healthcare in emerging countries may hinder the market growth. For instance, the OECD Development Co-operation Report 2020 highlighted the lack of clinical infrastructure, specific manufacturing processes, and more importantly, the financial resources in the developing world. Moreover, the Animal and Plant Health Inspection Service’s (APHIS) Center for Veterinary Biologics (CVB) regulates veterinary biologics products including animal vaccines. This regulation ensures the purity, safety, potency, and effectiveness of veterinary biologics for its use in the treatment and prevention of animal diseases.

Similarly, the European Medicines Agency (EMA) monitors the development and commercialization process of companion animal vaccines as per the technical requirements mentioned in Annex 1, Title II, to Directive 2001/82/EC, as amended by Directive 2009/9/EC, and the European Pharmacopoeia (Ph. Eur.). All commercially available animal vaccines undergo a stringent regulatory approval process and are required to meet exhaustive technical requirements. Thus, rigid regulatory framework and lack of technological & financial resources for vaccine development may impede the companion animal vaccines industry growth.

Companion Animal Vaccines Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

When it comes to vaccines for our furry friends, there are different types to choose fromlive attenuated, inactivated, recombinant, and others. In 2022, the live attenuated vaccine stole the show with over 45% of the market. And guess what? This trend is expected to continue. These live attenuated vaccines are like mini warriors against disease. They've been weakened in the lab, so while they still look like the real deal, they're too mellow to cause an infection. But don't let that fool you! They're super effective at teaching your pet's immune system to fight off the real bad guys. Most of the vaccines you see at the vet's office are live attenuated. They're not only great at protecting your pet, but they also last a long time and often just one dose is enough. Plus, they're relatively affordable in developing countries. All these perks make them the go-to choice for pet owners.

Learn more about the key segments shaping this market

 Download Free Sample

When it comes to vaccinating our furry friends, the market for companion animal vaccines focuses on four main typesdogs, cats, horses, and birds. Out of these, dogs have been the clear frontrunners, taking up over half of the market in 2022. And they're not slowing down anytime soon. The reason for this surge in popularity? More and more people are welcoming dogs into their families around the world. Places like the United Kingdom, Poland, and France have a particularly strong affinity for canine companions. This means more pet owners are looking for vaccines to keep their beloved dogs healthy, both core vaccines and those that protect against specific risks. So, with so many homes filled with furry canine friends, the companion animal vaccines market has a bright future ahead, especially in countries where dogs are the most popular companions.

When it comes to giving vaccines to pets, there are three main ways to do itshots, oral vaccines, and sprays. Right now, shots are the most popular option, making up the biggest slice of the pet vaccine market. Shots are given under the skin or into the muscle, and they're the best choice for diseases that require a strong immune response throughout the body. This is because shots help the vaccine spread throughout the body, protecting your pet against the disease. They also tend to cause fewer side effects at the injection site, like swelling or pain. Studies have shown that shots give pets the best immune protection, with fewer side effects. They're also more effective at triggering both short-lived and long-lasting immune responses, which is why vets often recommend them for serious diseases. Because of this, shots are likely to stay the most popular way to vaccinate pets in the future.

When it comes to buying vaccines for your furry friends, you've got a few options. You can head to the vet's office pharmacy, swing by a regular pharmacy, or shop online. Back in 2022, most people were getting their pet vaccines at the vet's pharmacy. And guess what? That's expected to keep growing over the next ten years. That's because vaccines are super important for keeping your pets healthy, and vets are the ones who usually give them. Many vet offices even have their own pharmacies where you can pick up any meds your pet needs. To make things even easier, vaccine companies are teaming up with vet clinics to make sure you can easily get your pet's shots right at the office. That means the future looks bright for getting your furry companions the protection they need.

Looking for region specific data?

 Download Free Sample

The pet vaccine market in North America is booming! In 2022, it was worth a ton of money, and it's expected to keep growing by a hefty 6.8% every year. Why is this market so huge? Well, it's all about our furry friends! More and more people are becoming pet parents, and they're realizing how important it is to keep their furry pals healthy. Plus, the number of diseases that can spread from animals to humans (called zoonotic diseases) is on the rise. In the United States alone, there are over 69 million pet dogs and 45 million pet cats. And guess what? Pet owners are spending more and more on their furry family members' healthcare. So, with more pets and more people spending money on their health, it's no wonder that the pet vaccine market is booming!

Companion Animal Vaccines Market Share

Major market players operating in the companion animal vaccines industry include

  • Elanco Animal Health Incorporated
  • Merck & Co., Inc
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc.

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Companion Animal Vaccines Industry News

  • In June 2021, Zoetis announced a collaboration with Canine Companions for Independence (CCI) to provide vaccines and other healthcare products to service dogs. This strategic engagement helped the company in strengthening its product offerings with respect to canine vaccines among other health products & services. 
  • In April 2021, Boehringer Ingelheim announced the launch of Feligen RCPCh, a new vaccine for cats that protects against several infectious diseases, including feline herpesvirus and calicivirus. This product launch helped the firm to bolster its position in the feline vaccine offerings and offered a competitive advantage.

The companion animal vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

By Vaccine Type

 

  • Live Attenuated
  • Inactivated
  • Recombinant
  • Others

By Animal Type

  • Canine
  • Feline
  • Equine
  • Avian

By Route of Administration

  • Injection Vaccines
  • Oral Vaccines
  • Spray Vaccines

By Distribution Channel

  • Veterinary Hospital Pharmacies
  • Retail Pharmacy
  • Online Stores

The above information is provided for the following regions and countries

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Poland
    • Sweden
    • The Netherlands
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Indonesia
    • Philippines
    • Malaysia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Columbia
    • Chile
    • Peru
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Turkey
    • Iran
    • Rest of MEA
       

Related Reports

Table of Content

Will be Available in the sample /Final Report. Please ask our sales Team.

List Tables Figures

Will be Available in the sample /Final Report. Please ask our sales Team.

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email